Our round-up of financings in the biotech sector this week is led by BioAge Lab's filing of an initial public offering (IPO), with a placeholder target of $100 million, plus sizeable private ...

President Donald Trump signed an executive order on Monday banning all federal funding for "dangerous" gain-of-function research ... drive global leadership in biotechnology, biosecurity, and ...

In a significant move to streamline and promote pharmaceutical exports, the Directorate General of Foreign Trade (DGFT) has issued Public Notice announcing the fixation of a new Standard Input Output ...

limit and track non-federally funded gain-of-function research” in the U.S. As of publication, the White House had not responded to questions from Fierce Biotech about which foreign countries ...

Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech ...

Data from Beacon’s interim six-month safety and efficacy results from a phase 2, announced May 6, pointed to improvements across “several key measures” of visual function, the private ...

The University of Chicago has received a $100 million gift from entrepreneur and investor Konstantin Sokolov. The donation will be used to support multiple components of the university’s ...

A Pittsburgh biotech startup has received a green light from federal regulators to test a groundbreaking treatment.

Title: Use of Expanded Non-genetically Modified Natural Killer Cells (Troculeucel) with Enhanced Cytotoxicity in Patients with Alzheimer's Disease. Preliminary Clinical and Biomarker Results.